Prognostic Impact of Pd-L1 Expression, Double Expressor Lymphoma, and Progression of Disease Within 24 Months in Primary Gastrointestinal Diffuse Large B-Cell Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.129_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Significance of Pd-L1 and Pd1 Receptors Expression in Patients With Diffuse B-Cell Large-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

PKC-beta II Expression Has Prognostic Impact in Nodal Diffuse Large B-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2007English

miR‑150 Is a Negative Independent Prognostic Biomarker for Primary Gastrointestinal Diffuse Large B‑cell Lymphoma

Oncology Letters
Cancer ResearchOncology
2020English

Primary Diffuse Large B-Cell Lymphoma of the Mandible

Autopsy and Case Reports
2019English

Epiphyseal Primary Diffuse Large B-Cell Lymphoma of Bone

Case Reports in Pathology
2018English

Primary Diffuse Large B-Cell Lymphoma of the Bladder

Internal Medicine
Internal MedicineMedicine
2009English

Diffuse Large B-Cell Lymphoma

2020English

Prognostic Impact of Diffuse Large B-Cell Lymphoma Subgroups in Patients Undergoing Autologous SCT

Bone Marrow Transplantation
TransplantationHematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy